Efficacy and safety of anti-angiogenic drugs combined with erlotinib in the treatment of advanced non-small cell lung cancer: a meta-analysis of randomized clinical trials
Crossref DOI link: https://doi.org/10.21037/apm-20-1621
Published Online: 2021-03
Published Print: 2021-03
Update policy: https://doi.org/10.21037/ame_crossmark_policy
Chen, Zheng
Jiang, Shu
Li, Xuechun
Zhang, Jingyao
Liu, Liu
Li, Juan
Cao, Peiyu
Xin, Yong
Zhang, Longzhen